Publication: Uracil with ftorafur and low dose oral folinic acid in advanced colorectal cancer
Issued Date
2001-08-01
Resource Type
ISSN
01252208
Other identifier(s)
2-s2.0-0035697088
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.84, No.8 (2001), 1142-1147
Suggested Citation
Surachat Chakrapee-Sirisuk, Pairoj Sinlarat, Darin Lohsiriwat, Narong Lert-Akayamanee, Thanyadej Nimmanwudipong, Vichien Srimuninnimit, Vithya Vathanophas, Pairoach Arch-Yaemsuan, Wiroon Boonnuch Uracil with ftorafur and low dose oral folinic acid in advanced colorectal cancer. Journal of the Medical Association of Thailand. Vol.84, No.8 (2001), 1142-1147. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/26732
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Uracil with ftorafur and low dose oral folinic acid in advanced colorectal cancer
Other Contributor(s)
Abstract
Background: Low dose oral Folinic acid was used together with uracil with ftorafur (UFT) producing some response with low toxicity in advanced colorectal cancer. However, the 28 day regimen produced 20 per cent severe (grade III, IV) diarrhea. This study required 21 days' treatment to evaluate the response rate and toxicity in advanced colorectal cancer. Method: UFT 300 mg/m2/day together with oral Folinic acid 7.5 mg/dose for 21 days with 7 days rest were required to treat 28 cases of recurrent or metastatic colorectal cancer. Results: Partial response was seen in 13.6 per cent of 22 evaluable cases and minimal response seen in 18.2 per cent. The majority (77%) of these patients had previously been treated with 5-fluorouracil (5-FU). These results are comparable to other studies. Toxicity was low with 3.3 per cent grade III, IV diarrhea. Conclusion: This regimen produced some activity in metastatic colorectal cancer with low toxicity.